DocCheck (Germany) Performance
| AJ91 Stock | EUR 12.60 0.40 3.08% |
DocCheck has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.25, which means not very significant fluctuations relative to the market. As returns on the market increase, DocCheck's returns are expected to increase less than the market. However, during the bear market, the loss of holding DocCheck is expected to be smaller as well. DocCheck AG right now shows a risk of 1.96%. Please confirm DocCheck AG semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to decide if DocCheck AG will be following its price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in DocCheck AG are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, DocCheck is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Forward Dividend Yield 0.0595 | Payout Ratio 0.6522 | Forward Dividend Rate 0.75 | Ex Dividend Date 2025-05-29 |
1 | Can DocCheck AG stock ride next bull market cycle - Trend Reversal Low Volatility Stock Recommendations - newser.com | 11/13/2025 |
2 | Can DocCheck AG stock reach 200 price target - 2025 Growth vs Value Long-Term Growth Stock Strategies - newser.com | 11/19/2025 |
3 | Is DocCheck AG stock a buy for dividend portfolios - Weekly Investment Recap Step-by-Step Swing Trade Plans - Newser | 12/01/2025 |
4 | Will DocCheck AG stock outperform Dow Jones - July 2025 Update Weekly Breakout Stock Alerts - ulpravda.ru | 01/08/2026 |
DocCheck |
DocCheck Relative Risk vs. Return Landscape
If you would invest 1,210 in DocCheck AG on November 8, 2025 and sell it today you would earn a total of 50.00 from holding DocCheck AG or generate 4.13% return on investment over 90 days. DocCheck AG is generating 0.0865% of daily returns assuming 1.9647% volatility of returns over the 90 days investment horizon. Simply put, 17% of all stocks have less volatile historical return distribution than DocCheck, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
DocCheck Target Price Odds to finish over Current Price
The tendency of DocCheck Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 12.60 | 90 days | 12.60 | about 21.93 |
Based on a normal probability distribution, the odds of DocCheck to move above the current price in 90 days from now is about 21.93 (This DocCheck AG probability density function shows the probability of DocCheck Stock to fall within a particular range of prices over 90 days) .
DocCheck Price Density |
| Price |
Predictive Modules for DocCheck
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DocCheck AG. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.DocCheck Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. DocCheck is not an exception. The market had few large corrections towards the DocCheck's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold DocCheck AG, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of DocCheck within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 0.25 | |
σ | Overall volatility | 0.71 | |
Ir | Information ratio | 0.01 |
DocCheck Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of DocCheck for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for DocCheck AG can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| About 72.0% of the company shares are held by company insiders |
DocCheck Fundamentals Growth
DocCheck Stock prices reflect investors' perceptions of the future prospects and financial health of DocCheck, and DocCheck fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DocCheck Stock performance.
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0916 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 48.96 M | ||||
| Shares Outstanding | 5.07 M | ||||
| Price To Earning | 18.89 X | ||||
| Price To Book | 1.65 X | ||||
| Price To Sales | 1.16 X | ||||
| Revenue | 53.78 M | ||||
| Gross Profit | 14.43 M | ||||
| EBITDA | 9.52 M | ||||
| Net Income | 5.28 M | ||||
| Cash And Equivalents | 10.42 M | ||||
| Cash Per Share | 2.09 X | ||||
| Total Debt | 18.05 M | ||||
| Debt To Equity | 0.10 % | ||||
| Book Value Per Share | 7.63 X | ||||
| Cash Flow From Operations | 7.64 M | ||||
| Earnings Per Share | 1.15 X | ||||
| Total Asset | 58.13 M | ||||
| Retained Earnings | 24.69 M | ||||
About DocCheck Performance
By analyzing DocCheck's fundamental ratios, stakeholders can gain valuable insights into DocCheck's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if DocCheck has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if DocCheck has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
DocCheck AG, through its subsidiaries, operates B2B portal for medical professionals in Europe. In addition, the company develops and implements communication strategies at the Cologne site based on media for the healthcare and B2B markets. DOCCHECK operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 248 people.Things to note about DocCheck AG performance evaluation
Checking the ongoing alerts about DocCheck for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DocCheck AG help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 72.0% of the company shares are held by company insiders |
- Analyzing DocCheck's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DocCheck's stock is overvalued or undervalued compared to its peers.
- Examining DocCheck's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DocCheck's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DocCheck's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DocCheck's stock. These opinions can provide insight into DocCheck's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DocCheck Stock analysis
When running DocCheck's price analysis, check to measure DocCheck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocCheck is operating at the current time. Most of DocCheck's value examination focuses on studying past and present price action to predict the probability of DocCheck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocCheck's price. Additionally, you may evaluate how the addition of DocCheck to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |